Suitability of Crushed Vibegron 75 mg Tablets for Enteral Administration.

Q2 Medicine
Jennifer Woo, Carla Washington, Dorothy Aikin, Rebecca Briggs Colamarino, Chad Worz, Laleh Abedinzadeh
{"title":"Suitability of Crushed Vibegron 75 mg Tablets for Enteral Administration.","authors":"Jennifer Woo, Carla Washington, Dorothy Aikin, Rebecca Briggs Colamarino, Chad Worz, Laleh Abedinzadeh","doi":"10.4140/TCP.n.2025.185","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b> Vibegron, a beta₃-adrenergic receptor agonist for overactive bladder, can be administered as an intact tablet or crushed and mixed with applesauce for patients with dysphagia. <b>Objectives</b> To evaluate the suitability of crushed vibegron for administration via enteral feeding tubes. <b>Methods</b> Vibegron 75 mg tablets were crushed, suspended in 15 mL water, and delivered through seven commonly used enteral tubes. Minimum required flush volume was assessed by flushing with 10, 20, or 30 mL water and quantifying dose delivery using high-performance liquid chromatography (HPLC). Material compatibility was assessed by holding doses in each tube for 5, 15, and 30 minutes and using HPLC to quantify dose delivery and detect impurities in vibegron and control (vibegron tablet) samples. Dosing repeatability was assessed by delivering six replicates through each tube and quantifying dose delivery. Tube occlusion was evaluated visually in all assays. Mean dose delivery through each tube was assessed using pooled data and analyzed by ANOVA. <b>Results</b> Delivery of > 90% was achieved in all assays, for all tubes assessed, with ≥ 20 mL flush volume; 5-, 15-, or 30-minute hold times; and delivery of 1 to 6 doses through the same tube. No additional impurities were detected in vibegron samples compared with controls. Tube occlusion was not observed. Mean dose delivery was > 95% for all tubes assessed and not significantly different between tubes (F = 1.02; <i>P</i> = 0.4). <b>Conclusions</b> Crushed vibegron tablets dispersed in 15 mL of water were delivered consistently and completely through a variety of enteral tubes with no evidence of material incompatibility or clogging.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"40 4","pages":"185-193"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2025.185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background Vibegron, a beta₃-adrenergic receptor agonist for overactive bladder, can be administered as an intact tablet or crushed and mixed with applesauce for patients with dysphagia. Objectives To evaluate the suitability of crushed vibegron for administration via enteral feeding tubes. Methods Vibegron 75 mg tablets were crushed, suspended in 15 mL water, and delivered through seven commonly used enteral tubes. Minimum required flush volume was assessed by flushing with 10, 20, or 30 mL water and quantifying dose delivery using high-performance liquid chromatography (HPLC). Material compatibility was assessed by holding doses in each tube for 5, 15, and 30 minutes and using HPLC to quantify dose delivery and detect impurities in vibegron and control (vibegron tablet) samples. Dosing repeatability was assessed by delivering six replicates through each tube and quantifying dose delivery. Tube occlusion was evaluated visually in all assays. Mean dose delivery through each tube was assessed using pooled data and analyzed by ANOVA. Results Delivery of > 90% was achieved in all assays, for all tubes assessed, with ≥ 20 mL flush volume; 5-, 15-, or 30-minute hold times; and delivery of 1 to 6 doses through the same tube. No additional impurities were detected in vibegron samples compared with controls. Tube occlusion was not observed. Mean dose delivery was > 95% for all tubes assessed and not significantly different between tubes (F = 1.02; P = 0.4). Conclusions Crushed vibegron tablets dispersed in 15 mL of water were delivered consistently and completely through a variety of enteral tubes with no evidence of material incompatibility or clogging.

Vibegron粉碎片75mg肠内给药的适宜性。
Vibegron是一种治疗膀胱过度活动的β 3 -肾上腺素能受体激动剂,可以作为完整的片剂或粉碎后与苹果酱混合给吞咽困难的患者服用。目的评价粉碎的维必隆用于肠内喂养管给药的适宜性。方法将Vibegron 75mg片粉碎,悬浮于15ml水中,经7条常用肠内管给药。通过用10、20或30 mL水冲洗和使用高效液相色谱(HPLC)定量剂量递送来评估所需的最小冲洗体积。通过在每个试管中分别保持剂量5、15和30分钟来评估材料相容性,并使用高效液相色谱法定量剂量传递并检测vibegron和对照(vibegron片)样品中的杂质。通过每管给药6次重复和定量给药来评估给药重复性。在所有的分析中,输卵管阻塞都是目测的。采用汇总数据评估每根管子的平均给药剂量,并采用方差分析进行分析。结果所有检测的试管中,bbb90 %的递送率均达到90%,冲洗量≥20 mL;5分钟、15分钟或30分钟的保持时间;通过同一根管子输送1到6剂。与对照组相比,在vibegron样品中未检测到额外的杂质。未观察到输卵管阻塞。所有被评估的试管的平均给药量为95%,试管之间无显著差异(F = 1.02;P = 0.4)。结论粉碎后的维必隆片分散于15ml水中,通过多种肠内管给药一致、完全,无材料配伍或堵塞现象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Senior Care Pharmacist
Senior Care Pharmacist PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
160
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信